Results 131 to 140 of about 145,799,037 (198)

Type 1 Cryoglobulinemic Glomerulonephritis With IgG2-Kappa Arising From Monoclonal Gammopathy of Undetermined Significance: A Case Report and Literature Review. [PDF]

Cureus
Al-Saedi ZS, Alatta L, Miqdad MA, Hulwi H, Rodriguez O, Yang Y, Kuo S.   +6 more
europepmc   +1 more source

Monoclonal gammopathy of undetermined significance in patients with solid tumours: Effects of immune checkpoint inhibitors on the monoclonal protein. [PDF]

Br J Haematol
Andrikopoulou A, Ntanasis-Stathopoulos I, Kokkali NA, Papanota AM, Migkou M, Malandrakis P, Spiliopoulou V, Liontos M, Zagouri F, Kaparelou M, Papatheodoridi A, Terpos E, Kastritis E, Dimopoulos MA, Gavriatopoulou M.   +14 more
europepmc   +1 more source

Monoclonal Gammopathy of Undetermined Significance Diagnosed by Persistent Anemia Following Living Kidney Transplantation: A Case Report. [PDF]

Cureus
Tomizawa M, Hori S, Inoue K, Yoneda T, Fujimoto K.   +4 more
europepmc   +1 more source

COVID-19-Associated Cold Agglutinin Syndrome and Hemophagocytosis in a Patient with Monoclonal Gammopathy of Undetermined Significance. [PDF]

Mediterr J Hematol Infect Dis
Yu Y, Yang K.
europepmc   +1 more source

Diffuse planar xanthomatosis in the setting of monoclonal gammopathy of undetermined significance. [PDF]

J Dermatol
Lenga M, Choi JN.
europepmc   +1 more source

The Importance of Chemokines Activating CXCR1, CXCR2 and CXCR3 in Tumorigenesis as Potential Therapeutic Targets in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma. [PDF]

Cancers (Basel)
Korbecki J, Barczak K, Bosiacka B, Surówka A, Duchnik E, Skarbiński M, Snarski E, Chlubek D, Bosiacki M.   +8 more
europepmc   +1 more source

Correction: Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis. [PDF]

Blood Cancer J
Maeng CV, Rögnvaldsson S, Einarsson Long T, Brieghel C, Hermansen E, Niemann CU, Grønbæk K, Kristinsson SY, Thorsteinsdóttir S.   +8 more
europepmc   +1 more source

Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis. [PDF]

Blood Cancer J
Maeng CV, Rögnvaldsson S, Einarsson Long T, Brieghel C, Hermansen E, Niemann CU, Grønbæk K, Kristinsson SY, Thorsteinsdóttir S.   +8 more
europepmc   +1 more source

Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification. [PDF]

Blood Cancer J
Gor R, Shivakumar J, Surana P, Wei J, Murakhovskaya I, Goldfinger M, Kornblum N, Shapiro L, Shastri A, Gupta R, Levitz D, Konopleva M, Feldman E, Gritsman K, Sica RA, Mantzaris I, Verma A, Cooper D, Janakiram M, Shah N.   +19 more
europepmc   +1 more source

Evaluation of Sarcopenia in Patients with Monoclonal Gammopathy of Undetermined Significance. [PDF]

J Clin Med
Kul AN, Kaya Tuna M.
europepmc   +1 more source